About Solarea Bio
Solarea Bio is a private company based in Waltham, Massachusetts. It has reported $37,237,009 raised in four offerings on Form D since September 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 2025 | Nov 20, 2025 | $9,910,397target not set | 5 | $1.9M | EquityRule 506(b) | Form D ↗ |
| Aug 27, 2024 | Sep 10, 2024 | $1,000,000target not set | 1 | $1.0M | EquityRule 506(b) | Form D ↗ |
| May 3, 2023 | May 9, 2023 | $14,999,999of $25.0M target | 4 | $3.7M | EquityRule 506(b) | Form D ↗ |
| Aug 31, 2020 | Sep 11, 2020 | $11,326,613of $14.8M target | 15 | $755K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $37,237,009 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Solarea Bio's Form D filed Nov 20, 2025.
NB
Neal Bhadkamkar
Director
MW
Matthew Walker
Director
AJ
Anula Jayasuriya
Director
GS
Gregory Sieczkiewicz
Director
CS
Catherine Balsam-Schwaber
Executive officer and director
ES
Eric Schott
Chief Operating Officer
Earlier filings also listed Ilissa Larimore (executive officer, last listed Sep 2024) and Gerardo Toledo (chief executive officer and director, last listed Sep 2024).